This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Eli Lilly and Company. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Shanthi Nagarajan: Innovator in cGAS Inhibitors
Introduction
Shanthi Nagarajan is a prominent inventor based in San Diego, California. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of cGAS inhibitors. Her work focuses on creating novel compounds that can be used to treat immune-mediated diseases.
Latest Patents
Shanthi Nagarajan holds a patent for cGAS inhibitors. The present invention relates to novel cGAS inhibitor compounds, which have a specific formula. These compounds are incorporated into pharmaceutical compositions and are designed to treat various pathological conditions, including immune-mediated diseases. She has 1 patent to her name.
Career Highlights
Shanthi Nagarajan is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role involves research and development of innovative therapeutic solutions. Her expertise in the field has positioned her as a valuable asset to her team and the company.
Collaborations
Some of her notable coworkers include Thibault Francois Varin and Adel Ahmed. Their collaborative efforts contribute to the advancement of research in the pharmaceutical industry.
Conclusion
Shanthi Nagarajan is a dedicated inventor whose work on cGAS inhibitors showcases her commitment to improving healthcare through innovative solutions. Her contributions are paving the way for new treatments for immune-mediated diseases.